About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,718 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,718 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 3,718 trials

CompletedA Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)This was an open-label, multicentric, prospective, post-marketing surveillance (PMS) study on the extent to which subject compliance is influenced by use of a variable titration…NCT01142492 CompletedIPX056 in Subjects With Established Spasticity Resulting From Multiple SclerosisThe purpose of this study is to determine the effects, both good and bad, of IPX056 on subjects and their spasticity.NCT00488839·Tucson, Arizona and 30 others

Related Searches

Data from ClinicalTrials.govTerms

RecruitingSwiss Multiple Sclerosis Cohort-StudyThe Swiss MS Cohort Study (SMSC) is a multicentre cohort study that involves 8 Swiss Multiple Sclerosis centres. The key aims of the SMSC are 1.NCT02433028·Aarau, Canton of Aargau and 7 others

Not yet recruitingEFFECTS OF AEROBIC AND RESISTANCE TRAINING ON IMMUNE FUNCTION IN MULTIPLE SCLEROSISBackground: Multiple Sclerosis (MS) is a chronic immune-mediated, inflammatory, and neurodegenerative central nervous system disorder characterized by axonal damage.NCT07640100·Van, Ipekyolu

CompletedEffect of Vitamin D Replacement on Immune Function and Cognition in MS PatientsAssessing the immune activation in MS patients deficient in Vitamin D and whether Vitamin D supplementation reverse the immune activation Evaluating whether Vitamin D deficiency…NCT01952483·Beirut, Riad El Solh

CompletedRelating Genetic and Environmental Risk Scores to Multiple Sclerosis SusceptibilityBackground: \- Research shows that both genes and the environment influence a person s risk for getting multiple sclerosis (MS).NCT01617395·Bethesda, Maryland

UnknowniTBS Study for Depression in Patients With Multiple SclerosisMultiple sclerosis (MS) is a chronic and demyelinating disease of the central nervous system. It is one of the most common cause of neurological disability in young adults.NCT04524039

CompletedCell Surface Marker Expression in Autoimmune DiseasesThis study is designed to explore the expression of cell-surface markers in the following seven disease areas: (a) systemic lupus erythematosus, (b) Sjogren's syndrome, (c)…NCT03757065·Vancouver, British Columbia and 1 other

Not yet recruitingGait Pattern and Its Relation to Cognition and VEP in Multiple SclerosisThis cross-sectional study aims to assess the pattern of gait in patients with multiple sclerosis and to evaluate its relation to cognitive function, visual evoked potentials, and…NCT07847086

WithdrawnImproving Mobility and Reducing Fatigue in People With Multiple Sclerosis by Electrical Stimulation TherapyThe objective of the clinical trial is to quantify the capacity of a translatable protocol of electrical nerve stimulation (TENS) to improve walking performance and self-reported…NCT03684369

WithdrawnRESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple SclerosisRESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Participants with Multiple…NCT07006805

CompletedRespiratory Function and Walking Capacity in Multiple SclerosisMultiple sclerosis (MS) is a chronic progressive neurological disease.NCT01774201

CompletedEfficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple SclerosisThe purpose of this study is to evaluate the efficacy and safety of Ocrelizumab produced by CinnaGen compared with Ocrevus® (Roche, Switzerland) in subjects with relapsing…NCT04966338·Rasht, Gilan Province and 14 others

CompletedTesting a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS)This study aims to test the efficacy of the EverydayMatters Multiple Sclerosis (MS) program for individuals age 45 or older living with multiple sclerosis.NCT03177785

CompletedStudy Evaluating Rapid Infusion Rituximab in Patients With Autoimmune DiseasesThe purpose of this study is to evaluate the impact of rapid infusion rituximab on the incidence of infusion-related reactions in patients with Autoimmune Diseases.NCT02040116·Winston-Salem, North Carolina

WithdrawnA Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune DiseasesThis is a prospective, single-arm, open-label, dose-exploration and expansion clinical study of LCAR-AIO in adult subjects with relapsed/refractory neurological autoimmune…NCT06869278·Fuzhou and 2 others

CompletedStabilometric Assessment of Balance Recovery in Persons With Multiple SclerosisBackground: Balance control relies on accurate perception of visual, somatosensory and vestibular cues.NCT02131285·Milan

UnknownRituximab-Induced Hypogammaglobulinemia in Multiple SclerosisB cells are considered major contributors to multiple sclerosis (MS) pathogenesis, a role that has taken on renewed importance with the advent of B-cell-depleting therapies.NCT04283747·Sari

CompletedLipoic Acid as a Treatment for Acute Optic NeuritisThe purpose of this study is to determine if oral lipoic acid can safely help relieve permanent optic nerve injury in patients diagnosed with acute optic neuritis.NCT01294176·Portland, Oregon

TerminatedInfluence of Cognitive Function Software Therapy on the Improvement of Manual Skills in Multiple Sclerosis PatientsMultiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system leading to the impairment of motor, visual and cognitive functions.NCT03693118·Szczecin, Unii Lubelskiej

PreviousPage 5 of 186Next